Healthcare

NICE Approves Enhertu for NHS Use in England, Expanding Access to Breast Cancer Drug

Around 1,000 women a year expected to become eligible for treatment following reversal of earlier funding rejection

By
Distilled Post Editorial Team
Technology

Palantir Appoints Tom Watson as UK Senior Vice President Amid NHS Contract Scrutiny

Former Labour deputy leader takes on role focused on ensuring public contracts support British jobs, as company faces criticism over major government deal
Business

Bank of England Maintains Base Rate Amid Global Economic Pressures

Policymakers hold steady at 3.75% despite rising inflation and oil prices linked to the ongoing conflict in Iran.

Healthcare

View All

Psychiatrist Brings Tribunal Claim Against NHS Trust Over Trans Patient Policy

Group Chief Executive's Departure Marks Leadership Change at Liverpool Hospital Trust

GPs Vote to Pause Escalation of Collective Action to Reset Relations with Government

Judge Appointed to Chair Public Inquiry Into Mental Health Trust Failings

NHS Proposes New Diagnosis Approach for ADHD Amid Rising Concerns

Business

Browse Category

Bank of England Maintains Base Rate Amid Global Economic Pressures

Policymakers hold steady at 3.75% despite rising inflation and oil prices linked to the ongoing conflict in Iran.

Reynolds Warns Against Tariffs on Chinese Electric Vehicles

Business Secretary says retaliatory measures from Beijing could threaten UK's export-led automotive sector

Reform UK Calls on Chancellor Healey to Halt Bank of England Bond Sales

Richard Tice claims stopping quantitative tightening programme could save taxpayers nearly £100bn, as Bank prepares changes to its approach

State Steps In to Rescue Speciality Steel UK After Private Deal Collapses

Business Secretary Jonathan Reynolds announces state move after private sale falls through, safeguarding over 1,300 jobs across four sites

Technology

Browse Category

Amodei's Call to Slow AI Development Draws Fire From Industry Critics

Anthropic chief executive's "Pacing the Frontier" proposal accused of serving commercial self-interest rather than genuine safety concerns

Durham Spinout Magnitude Biosciences Raises £1.3m to Expand Drug Discovery Platform

Investment led by Northstar Ventures will fund expansion of VivoScan, a screening technology using nematode worms to test drug candidates

Oxford Biomedica Faces Near-Term Setback Despite Strong Growth Forecasts

Analysts project sharp earnings growth for the gene therapy manufacturer even as guidance is cut and a US facility delay weighs on 2026 revenue

Gulf Capital Finds Its Way Into Britain's Pathology Labs

Circle Health Group's diagnostics deal with PureHealth signals how sovereign money is quietly reshaping the plumbing of UK healthcare

We aim to expose our readers to new ideas and ways of thinking, bring new companies valuable exposure and transforming our futures with a platform that is inclusive and diverse in both content and people.
ContactPrivacy Policy
Distil MarketingArchive